146 related articles for article (PubMed ID: 18307839)
1. Patient and physician perspectives on the attributes of nasal allergy medications.
Naclerio RM; Hadley JA; Stoloff S; Nelson HS
Allergy Asthma Proc; 2007; 28 Suppl 1():S11-7. PubMed ID: 18307839
[TBL] [Abstract][Full Text] [Related]
2. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
Wingertzahn MA; Derebery MJ; Nelson HS
Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
[TBL] [Abstract][Full Text] [Related]
3. Nasal allergies in the Middle Eastern population: results from the "Allergies in Middle East Survey".
Abdulrahman H; Hadi U; Tarraf H; Gharagozlou M; Kamel M; Soliman A; Hamad WA; Hanna KM; Mostafa BE; Omrani M; Abdelmotal A; Moukarzel N
Am J Rhinol Allergy; 2012; 26 Suppl 1():S3-23. PubMed ID: 23232281
[TBL] [Abstract][Full Text] [Related]
4. Intranasal corticosteroids in the treatment of allergic rhinitis.
Ratner PH; Stoloff S; Meltzer EO; Hadley JA
Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
[TBL] [Abstract][Full Text] [Related]
5. Ciclesonide, a hypotonic intranasal corticosteroid.
Neffen H; Wingertzahn MA
Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
[TBL] [Abstract][Full Text] [Related]
6. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys.
Meltzer EO; Blaiss MS; Naclerio RM; Stoloff SW; Derebery MJ; Nelson HS; Boyle JM; Wingertzahn MA
Allergy Asthma Proc; 2012; 33 Suppl 1():S113-41. PubMed ID: 22981425
[TBL] [Abstract][Full Text] [Related]
7. Patient and healthcare-provider perspectives on the burden of allergic rhinitis.
Blaiss MS; Meltzer EO; Derebery MJ; Boyle JM
Allergy Asthma Proc; 2007; 28 Suppl 1():S4-10. PubMed ID: 18307838
[TBL] [Abstract][Full Text] [Related]
8. Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis.
Long AA
Clin Ther; 2007 Feb; 29(2):342-51. PubMed ID: 17472826
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone furoate: a new intranasal corticosteroid.
Kumar R; Kumar D; Parakh A
J Postgrad Med; 2012; 58(1):79-83. PubMed ID: 22387656
[TBL] [Abstract][Full Text] [Related]
10. Nasal allergies in the Middle Eastern population: Results from the "Allergies in Middle East Survey".
Abdulrahman H; Hadi U; Tarraf H; Gharagozlou M; Kamel M; Soliman A; Hamad WA; Hanna KM; Mostafa BE; Omrani M; Abdelmotal A; Moukarzel N
Am J Rhinol Allergy; 2012 Nov; 26(6):3-23. PubMed ID: 29025459
[TBL] [Abstract][Full Text] [Related]
11. Nasal allergies in the Latin American population: results from the Allergies in Latin America survey.
Neffen H; Mello JF; Sole D; Naspitz CK; Dodero AE; Garza HL; Guerra EN; Baez-Loyola C; Boyle JM; Wingertzahn MA
Allergy Asthma Proc; 2010; 31 Suppl 1():S9-27. PubMed ID: 20557683
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
Karaki M; Akiyama K; Mori N
Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
[TBL] [Abstract][Full Text] [Related]
13. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
Blaiss MS
Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.
Mahadevia PJ; Shah S; Leibman C; Kleinman L; O'Dowd L
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):345-50. PubMed ID: 15521370
[TBL] [Abstract][Full Text] [Related]
15. Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific Survey.
Katelaris CH; Lai CK; Rhee CS; Lee SH; Yun WD; Lim-Varona L; Quang VT; Hwang J; Singh H; Kim J; Boyle JM; Dhong HJ; Narayanan P; Vicente G; Blaiss M; Sacks R
Am J Rhinol Allergy; 2011; 25 Suppl 1():S3-15. PubMed ID: 22185687
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis.
van Bavel JH; Ratner PH; Amar NJ; Hampel FC; Melchior A; Dunbar SA; Dorinsky PM; Tantry SK
Allergy Asthma Proc; 2012; 33(5):386-96. PubMed ID: 23026180
[TBL] [Abstract][Full Text] [Related]
17. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis.
Chervinsky P; Kunjibettu S; Miller DL; Prenner BM; Raphael G; Hall N; Shah T
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):69-76. PubMed ID: 17650833
[TBL] [Abstract][Full Text] [Related]
19. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey.
Meltzer EO; Blaiss MS; Derebery MJ; Mahr TA; Gordon BR; Sheth KK; Simmons AL; Wingertzahn MA; Boyle JM
J Allergy Clin Immunol; 2009 Sep; 124(3 Suppl):S43-70. PubMed ID: 19592081
[TBL] [Abstract][Full Text] [Related]
20. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
Bachert C; El-Akkad T
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
